May 2021

Yaron Conforti, CEO of Novamind

No new episode of the Green Rush this week, instead we’re replaying an old favorite, our conversation with Yaron Conforti, CEO and Director of Novamind Ventures, which delivers psychedelic therapies to patients suffering from treatment resistant psychological conditions at its Cedar Psychiatry clinics in Utah. 

Novamind is evolving the model of regulated psychedelic medicine by treating patients with ketamine-assisted psychotherapy at its four Cedar Psychiatry clinics in Utah; creating complementary evidence-based therapy modalities that enhance patient outcomes; and, building a network of outpatient mental health clinics and clinical research sites in jurisdictions with established regulations for the use of psychedelics. 

Related Posts